Dexmedetomidine and Bupivacaine With Bupivacaine in Ultrasonography Guided Fascia Iliaca Compartment Block in Adults

Comparison of Dexmedetomidine and Bupivacaine With Bupivacaine Alone on the Quality of Ultrasonography Guided Fascia Iliaca Compartment Block in Adults Undergoing Femur Fracture Fixation Surgery

Status

UNKNOWN

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02658760

Enrollment

Registered

2016-01-20

Start date

2015-06-30

Completion date

2016-12-31

Last updated

2016-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Femoral Fractures

Keywords

Femoral Fractures

Brief summary

Few studies have reported the efficacy of adding dexmedetomidine to bupivacain for fascia illiaca compartment black. Comparison of dexmedetomidine and bupivacaine with bupivacaine alone on the quality of ultrasonography guided fascia iliaca compartment block in adults undergoing femur fracture fixation surgery at 2014.

Interventions

DRUGDexmedetomidine

dexmedetomidine plus placebo

DRUGBupivacaine

dexmedetomidine and Bupivacaine

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

14 Years to No maximum

Healthy volunteers

Inclusion criteria

* Adults with femural fracture

Exclusion criteria

* Hypersensitivity to drugs * Neurological diseases * Coagulation abnormalities * Infection at the site of block

Design outcomes

Primary

Measure	Time frame	Description
Pain	24 hours	A point between 0 and 10 based on patient report

Secondary

Measure	Time frame	Description
Respiratory depression	24 hours	respiratory rate \< 12/min
Hypotension	24 hours	Systolic blood pressure \< 90 mmHg
Baradycardia	24 hours	Heart rate \< 60/min

Countries

Iran

Contacts

Primary ContactHamidreza Mahboobi

hamidrezamahboobi@yahoo.com9172121995

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026